Abstract
Background and aimSarcopenic obesity is a risk factor of morbidity and mortality. The aim of this study was to generate a predictive score of sarcopenia occurrence one year after bariatric surgery.Patients and methodsWe conducted an observational prospective cohort study on a total of 184 severely obese patients admitted to our institution to undergo sleeve gastrectomy. Skeletal muscle cross-sectional area at the third lumbar vertebrae (SMA, cm2) was measured from the routinely performed computed tomography. The skeletal muscle index (SMI) was calculated as follows: SMA/height2 (cm2/m2). Sarcopenia was defined as an SMI < 38.5 cm2/m2 for women and < 52.4 cm2/m2 for men. Measurements were performed at surgery and one year later.ResultsMost of the included patients were female (79%), with a mean age of 42±0.9 years and body mass index of 43.2±0.5 kg/m2. Fifteen patients (8%) had sarcopenia before surgery and 59 (32%) at the one-year follow-up. Male gender (p<0.0001), SMA before surgery (p<0.0001), and SMI before surgery (p<0.0001) significantly correlated with the occurrence of sarcopenia one year after surgery by multivariate analysis. Two predictive sarcopenia occurrence scores were constructed using SMA and gender (SS1 score) or SMI and gender (SS2 score). The area under receiver operating characteristic (AUROC) curve of the SS2 score was significantly greater than that of the SS1 score for the diagnosis of postoperative sarcopenia occurrence (0.95±0.02 versus 0.90±0.02; p<0.01). A cut-off value for the SS2 score of 0.53 had a sensitivity of 90%, a specificity of 91%, a positive predictive value of 83%, and a negative predictive value of 95%. In the group of patients without baseline sarcopenia, the SS2 score had still an excellent AUROC of 0.92±0.02. A cut-off of 0.55 predicted development of sarcopenia one year after sleeve gastrectomy in these patients with a sensitivity of 87%, a specificity of 88%, and negative predictive value of 95%.ConclusionThe SS2 score has excellent predictive value for the occurrence of sarcopenia one year after sleeve gastrectomy. This score can be used to target early intensification of nutritional and dietetic follow-up to the predicted high-risk population.
Highlights
Sarcopenia is a pathological disorder characterized by generalized loss of skeletal muscle mass and function
The area under receiver operating characteristic (AUROC) curve of the Sarcopenia score 2 (SS2) score was significantly greater than that of the Sarcopenia score 1 (SS1) score for the diagnosis of postoperative sarcopenia occurrence (0.95±0.02 versus 0.90±0.02; p
Sarcopenia is associated with the severity of fibrosis and steatosis, independently of metabolic risk factors, in patients with nonalcoholic fatty liver disease (NAFLD) [4]
Summary
Sarcopenia is a pathological disorder characterized by generalized loss of skeletal muscle mass and function. It is a risk factor of physical disability, impaired quality of life, and death [1, 2]. Sarcopenia is associated with the severity of fibrosis and steatosis, independently of metabolic risk factors, in patients with nonalcoholic fatty liver disease (NAFLD) [4]. Men with an SMI < 52.4 cm2/m2 and women with an SMI < 38.5 cm2/m2 are sarcopenic and have a poorer functional status and higher mortality [7] These cut-points have further been linked to adverse outcomes in various populations including the intensive care unit, cancer and liver disease patients [8,9,10]. The aim of this study was to generate a predictive score of sarcopenia occurrence one year after bariatric surgery
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.